Intra-Cellular Therapies (ITCI) – Trader Talk
-
Neurocrine Biosciences (NBIX), Intra-Cellular Therapies (ITCI), and Biohaven Pharmaceutical (BHVN) Are Top Potential Acquisition Targets for Biogen (BIIB) - Mizuho Investor Survey
-
Intra-Cellular Therapies (ITCI) Adds to Yesterday's Gain, Up 12% Pre-Market
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ITCI Stock Lookup